(Q38561865)

4 September 2017

1 reference

title

Linking insulin with Alzheimer's disease: emergence as type III diabetes (English)

1 reference

4 September 2017

0 references

Sara Ahmed

1

1 reference

PubMed ID

26248483

4 September 2017

Zahra Mahmood

series ordinal

2

1 reference

PubMed ID

26248483

4 September 2017

Saadia Zahid

series ordinal

3

1 reference

4 September 2017

7 August 2015

1 reference

4 September 2017

Neurological Sciences

1 reference

4 September 2017

36

1 reference

4 September 2017

10

1 reference

4 September 2017

1763-1769

1 reference

https://scigraph.springernature.com/pub.10.1007/s10072-015-2352-5

4 September 2017

0 references

cites work

Probing the biology of Alzheimer's disease in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Alzheimer disease: Insulin resistance and AD--extending the translational path.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Brain insulin signaling and Alzheimer's disease: current evidence and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Insulin receptors are widely distributed in the central nervous system of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Insulin in the Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Phosphorylation of IRS proteins, insulin action, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Role of insulin and insulin receptor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Improving influence of insulin on cognitive functions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Intranasal insulin improves memory in humans: superiority of insulin aspart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Role for neuronal insulin resistance in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Alzheimer's disease is type 3 diabetes-evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Increased risk of type 2 diabetes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Common pathological processes in Alzheimer disease and type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-015-2352-5

Insulin in the brain: a hormonal regulator of energy balance

21 January 2018

1 reference

12 December 2020

Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's disease.

1 reference

12 December 2020

Amyloid beta oligomers induce impairment of neuronal insulin receptors

1 reference

12 December 2020

Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

Insulin and Alzheimer's disease: untangling the web.

1 reference

12 December 2020

Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease

1 reference

12 December 2020

Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration

1 reference

12 December 2020

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

12 December 2020

GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.

1 reference

12 December 2020

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine

1 reference

12 December 2020

Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction

1 reference

12 December 2020

Alzheimer's disease: genes, proteins, and therapy

1 reference

12 December 2020

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

1 reference

12 December 2020

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease

1 reference

12 December 2020

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.

1 reference

12 December 2020

Insulin signaling, diabetes mellitus and risk of Alzheimer disease.

1 reference

12 December 2020

Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

1 reference

12 December 2020

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

1 reference

12 December 2020

10.1007/S10072-015-2352-5

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26248483